In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...
Rachael Buck, PhD, discusses the potential of a new infant formula she and her research team developed, which harnesses the unique qualities and benefits of human milk oligosaccharides (an alternative...
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults with AATD has...
Bruce Given, MD, discusses alpha-1 antitrypsin deficiency (AATD) treatment methods, including enzyme therapy and gene therapy, and the hope that advancements in replacement therapy will improve treatments...
